Nothing Special   »   [go: up one dir, main page]
create a website
Direct to consumer advertising in pharmaceutical markets. (2006). Kuhn, Michael ; Brekke, Kurt.
In: Journal of Health Economics.
RePEc:eee:jhecon:v:25:y:2006:i:1:p:102-130.

Full description at Econpapers || Download paper

Cited: 33

Citations received by this document

Cites: 30

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Competing with precision: incentives for developing predictive biomarker tests. (2022). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2022_006.

    Full description at Econpapers || Download paper

  2. Analysis of Risk Factors in the Channels of Drug Distribution: Professional Perspectives. (2020). Fajsi, Angela ; Moraa, Slobodan ; Gruji, Jelena.
    In: Sustainability.
    RePEc:gam:jsusta:v:12:y:2020:i:11:p:4787-:d:370184.

    Full description at Econpapers || Download paper

  3. The Unexpected Consequences of Generic Entry. (2019). Ornaghi, Carmine ; Castanheira, Micael ; Siotis, Georges ; de Moura, Micael Castanheira .
    In: ULB Institutional Repository.
    RePEc:ulb:ulbeco:2013/298643.

    Full description at Econpapers || Download paper

  4. The unexpected consequences of generic entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:68:y:2019:i:c:s0167629618305332.

    Full description at Econpapers || Download paper

  5. The Unexpected Consequences of Generic Entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Working Papers ECARES.
    RePEc:eca:wpaper:2013/293928.

    Full description at Econpapers || Download paper

  6. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws. (2018). Richards, Michael R ; Nathenson, Robert.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:18:y:2018:i:3:d:10.1007_s10754-018-9234-3.

    Full description at Econpapers || Download paper

  7. The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma. (2017). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael ; de Frutos, Maria-Angeles .
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:11813.

    Full description at Econpapers || Download paper

  8. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication. (2015). Bradford, W. David ; Kleit, Andrew N..
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:7:p:859-875.

    Full description at Econpapers || Download paper

  9. The effects of direct-to-consumer advertising of pharmaceuticals on adherence. (2015). , Cardon .
    In: Applied Economics.
    RePEc:taf:applec:v:47:y:2015:i:50:p:5432-5444.

    Full description at Econpapers || Download paper

  10. The Regulation of Direct-to-Consumer Advertising of Pharmaceuticals in a Managed Care Setting. (2015). Ryan, Matthew ; Vaithianathan, Rhema .
    In: Journal of Public Economic Theory.
    RePEc:bla:jpbect:v:17:y:2015:i:6:p:986-1021.

    Full description at Econpapers || Download paper

  11. Direct to Consumer Advertising of Pharmaceutical Drugs: Information and Persuasion. (2014). Bar, Talia ; Lillard, Dean R..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19794.

    Full description at Econpapers || Download paper

  12. Effects of Pharmaceutical Promotion: A Review and Assessment. (2013). Dave, Dhaval.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:18830.

    Full description at Econpapers || Download paper

  13. The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space. (2013). Venkataraman, Sriram ; Landsman, Vardit ; Stremersch, Stefan .
    In: Marketing Science.
    RePEc:inm:ormksc:v:32:y:2013:i:1:p:89-110.

    Full description at Econpapers || Download paper

  14. Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?. (2013). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:1:p:268-285.

    Full description at Econpapers || Download paper

  15. Informing the uninformed: How drug advertising affects check-up visits. (2013). Wendling, Brett ; Hosken, Daniel .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:181-194.

    Full description at Econpapers || Download paper

  16. Direct-to-consumer advertising and consumer welfare. (2013). Jayawardhana, Jayani .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:164-180.

    Full description at Econpapers || Download paper

  17. Quality competition with motivated providers and sluggish demand. (2013). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto.
    In: Journal of Economic Dynamics and Control.
    RePEc:eee:dyncon:v:37:y:2013:i:10:p:2041-2061.

    Full description at Econpapers || Download paper

  18. Impact of Direct?to?Consumer Advertising on Pharmaceutical Prices and Demand. (2012). Saffer, Henry ; Dave, Dhaval.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:79:y:2012:i:1:p:97-126.

    Full description at Econpapers || Download paper

  19. Misleading advertising in duopoly. (2012). Hattori, Keisuke ; Higashida, Keisaku.
    In: Canadian Journal of Economics/Revue canadienne d'économique.
    RePEc:wly:canjec:v:45:y:2012:i:3:p:1154-1187.

    Full description at Econpapers || Download paper

  20. Role of Socioeconomic Status on Consumers’ Attitudes Towards DTCA of Prescription Medicines in Australia. (2012). Lee, Johnson ; Chaar, Betty .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:105:y:2012:i:4:p:447-460.

    Full description at Econpapers || Download paper

  21. Direct to Consumer Advertising for Pharmaceuticals: Research Amid the Controversy. (2012). Kleit, Andrew N. ; Bradford, David W..
    In: Chapters.
    RePEc:elg:eechap:14021_31.

    Full description at Econpapers || Download paper

  22. Can Credence Advertising Effects Be Isolated? Can They Be Negative?: Evidence from Pharmaceuticals. (2011). Kleit, Andrew N ; Bradford, David W.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:78:y:2011:i:1:p:167-190.

    Full description at Econpapers || Download paper

  23. Competition and quality in health care markets: A differential-game approach. (2010). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:4:p:508-523.

    Full description at Econpapers || Download paper

  24. Marketing and societal welfare: A multiple stakeholder approach. (2010). Matear, Margaret ; Dacin, Peter A..
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:63:y:2010:i:11:p:1173-1178.

    Full description at Econpapers || Download paper

  25. Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?. (2010). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8076.

    Full description at Econpapers || Download paper

  26. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. (2010). Richards-Shubik, Seth ; Markowitz, Sara ; David, Guy.
    In: American Economic Journal: Economic Policy.
    RePEc:aea:aejpol:v:2:y:2010:i:4:p:1-25.

    Full description at Econpapers || Download paper

  27. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. (2009). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1141-1153.

    Full description at Econpapers || Download paper

  28. Competition and quality in regulated markets: a differential-game approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Discussion Papers.
    RePEc:yor:yorken:08/05.

    Full description at Econpapers || Download paper

  29. Competition and Quality in Regulated Markets: a Differential-Game Approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:6801.

    Full description at Econpapers || Download paper

  30. Pharmaceutical Patents: Incentives for R&D or Marketing?. (2008). Straume, Odd Rune ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_2433.

    Full description at Econpapers || Download paper

  31. Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs. (2008). Linnosmaa, Ismo.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:8:y:2008:i:2:n:8.

    Full description at Econpapers || Download paper

  32. Advertising and generic market entry. (2007). Konigbauer, Ingrid .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:26:y:2007:i:2:p:286-305.

    Full description at Econpapers || Download paper

  33. Dealing with Rising Health Care Costs: The Case of Pharmaceuticals. (2006). Konigbauer, Ingrid .
    In: Munich Dissertations in Economics.
    RePEc:lmu:dissen:5640.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Azoulay, P. Do pharmaceutical sales respond to scientific evidence?. 2002 Journal of Economics and Management Strategy. 11 551-594

  2. Berndt, E.R. ; Bui, L. ; Reiley, D. ; Urban, G. Information, marketing, and pricing in the U.S. antiulcer drug market. 1995 American Economic Review, Papers and Proceedings. 85 100-105

  3. Berndt, E.R. ; Bui, L. ; Reiley, D. ; Urban, G. The roles of marketing, product quality and price competition in the growth and composition of the U.S. anti-ulcer drug industry. 1997 En : Bresnahan, T.F. ; Gordon, R.J. The Economics of New Goods. Studies in Income and Wealth, vol. 58. University of Chicago Press: Chicago
    Paper not yet in RePEc: Add citation now

  4. Butters, G. Equilibrium distributions of sale and advertising prices. 1977 Review of Economic Studies. 44 465-491

  5. Cabrales, A. Pharmaceutical Generics, Vertical Product Differentiation and Public Policy. 2004 Universitat Pompeu Fabra: Mimeo

  6. Calfee, J.E. ; Winston, C. ; Stempski, R. Direct-to-consumer advertising and the demand for cholesterol-reducing drugs. 2002 Journal of Law and Economics XLV. 673-689

  7. Dorfman, R. ; Steiner, P.O. Optimal advertising and optimal quality. 1954 American Economic Review. 44 826-836
    Paper not yet in RePEc: Add citation now

  8. Eckard, E.W. Competition and the cigarette TV advertising ban. 1991 Economic Inquiry. 29 119-133

  9. Fudenberg, D. ; Tirole, J. The fat-cat effect, the puppy-dog ploy, and the lean and hungry look. 1984 American Economic Review, Papers and Proceedings. 74 361-366

  10. Grabowski, H.G. ; Vernon, J. Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act. 1992 Journal of Law and Economics. 35 331-350

  11. Grossman, G. ; Shapiro, C. Informative advertising with differentiated products. 1984 Review of Economic Studies. 51 63-81

  12. Hurwitz, M.A. ; Caves, R.E. Persuasion or information? Promotion and shares of brand name and generic pharmaceuticals. 1988 Journal of Law and Economics. 31 299-320

  13. Iizuka, T. What explains the use of direct-to-consumer advertising of prescription drugs?. 2004 Journal of Industrial Economics. LII 349-379

  14. Iizuka, T. ; Jin, G.Z. The effects of prescription drug advertising on doctor visits.. 2005 Journal of Economics & Management Strategy. 14 701-727
    Paper not yet in RePEc: Add citation now
  15. Königbauer, I. Advertising and generic market entry. 2004 University of Munich: Mimeo
    Paper not yet in RePEc: Add citation now
  16. Konrad, K., 2002. Competition for prescription drugs. Mimeo, Wissenschaftszentrum Berlin.
    Paper not yet in RePEc: Add citation now

  17. Leffler, K.B. Persuasion or information? The economics of prescription drug advertising. 1981 Journal of Law and Economics. 24 45-74

  18. Ling, D.C. ; Berndt, E.R. ; Kyle, M.K. Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter product sales. 2002 Journal of Law and Economics. XLV 691-723

  19. Lu, J.L. ; Comanor, W.S. Strategic pricing of new pharmaceuticals. 1998 Review of Economics and Statistics. 80 108-118

  20. Lundin, D. Moral Hazard in physician prescription behavior. 2000 Journal of Health Economics. 19 639-662

  21. Mossialos, E. Regulating Expenditure on Medicines in European Union Countries. 1998 En : Saltman, R.B. ; Figueras, J. ; Sakellarides, C. Critical Challenges for Health Care Reform in Europe. Open University Press: Buckingham and Philadelphia
    Paper not yet in RePEc: Add citation now

  22. Rizzo, J.A. Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. 1999 Journal of Law and Economics. 42 89-116

  23. Rosenthal, M.B. ; Berndt, E.R. ; Donohue, J.M. ; Frank, R.G. ; Epstein, A.M. Promotion of prescription drugs to consumers. 2002 New England Journal of Medicine. 346 498-504
    Paper not yet in RePEc: Add citation now

  24. Rubin, P.H. ; Schrag, J.L. Mitigating agency problems by advertising, with special reference to managed health care. 1999 Southern Economic Journal. 66 39-60

  25. Scherer, F.M. The pharmaceutical industry. 2000 En : Cuyler, A.J. ; Newhouse, J.P. Handbook of Health Economics. Elsevier: North Holland, Amsterdam

  26. Scherer, F.M. ; Ross, D. Industrial Market Structure and Economic Performance. 1990 Houghton Mifflin Company: Boston
    Paper not yet in RePEc: Add citation now
  27. Schweitzer, S.O. Pharmaceutical Economics and Policy. 1997 Oxford University Press: New York
    Paper not yet in RePEc: Add citation now

  28. Scott Morton, F.M. Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. 2000 International Journal of Industrial Organization. 18 1085-1104

  29. Wilkes, M.S. ; Bell, R.A. ; Kravitz, R.L. Direct-to-consumer prescription drug advertising: trends, impact and implications. 2000 Health Affairs (Millwood). 19 110-128
    Paper not yet in RePEc: Add citation now
  30. Zweifel, P. ; Breyer, F. Health Economics. 1997 Oxford University Press: New York
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Do Firms Publish? A Multi-Sectoral Analysis. (2018). Rotolo, Daniele ; Grassano, Nicola ; Camerani, Roberto.
    In: SPRU Working Paper Series.
    RePEc:sru:ssewps:2018-21.

    Full description at Econpapers || Download paper

  2. Do firms publish? A multi-sectoral analysis. (2018). Rotolo, Daniele ; Grassano, Nicola ; Camerani, Roberto.
    In: JRC Working Papers on Corporate R&D and Innovation.
    RePEc:ipt:wpaper:201805.

    Full description at Econpapers || Download paper

  3. Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting. (2018). Salandra, Rossella.
    In: Research Policy.
    RePEc:eee:respol:v:47:y:2018:i:7:p:1215-1228.

    Full description at Econpapers || Download paper

  4. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiutil:be3f3c38-5e39-4a67-af57-820c14957e0b.

    Full description at Econpapers || Download paper

  5. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiucen:6ee607fc-8602-4270-a076-3b0a18f71366.

    Full description at Econpapers || Download paper

  6. How does the partner type in R&D alliances impact technological innovation performance? A study on the Korean biotechnology industry. (2016). Park, Gunno ; Ji, Sang ; Shin, Kwangsoo.
    In: Asia Pacific Journal of Management.
    RePEc:kap:asiapa:v:33:y:2016:i:1:d:10.1007_s10490-015-9439-7.

    Full description at Econpapers || Download paper

  7. Corporate Science, Innovation, and Firm Value. (2016). Cincera, Michele ; Simeth, Markus .
    In: Management Science.
    RePEc:inm:ormnsc:v:62:y:2016:i:7:p:1970-1981.

    Full description at Econpapers || Download paper

  8. Brand Performance Volatility from Marketing Spending. (2016). Shin, Hyun Song ; Fischer, Marc ; Hanssens, Dominique M.
    In: Management Science.
    RePEc:inm:ormnsc:v:62:y:2016:i:1:p:197-215.

    Full description at Econpapers || Download paper

  9. The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs. (2016). Horstmann, Ignatius ; Clark, Robert ; Ching, Andrew ; Lim, Hyunwoo.
    In: Marketing Science.
    RePEc:inm:ormksc:v:35:y:2016:i:1:p:158-181.

    Full description at Econpapers || Download paper

  10. Killing the Golden Goose? The Decline of Science in Corporate R&D. (2015). Belenzon, Sharon ; Arora, Ashish ; Patacconi, Andrea.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:20902.

    Full description at Econpapers || Download paper

  11. How do firms develop capabilities for scientific disclosure?. (2015). Lhuillery, Stephane ; Simeth, Markus .
    In: Research Policy.
    RePEc:eee:respol:v:44:y:2015:i:7:p:1283-1295.

    Full description at Econpapers || Download paper

  12. The Regulation of Direct-to-Consumer Advertising of Pharmaceuticals in a Managed Care Setting. (2015). Ryan, Matthew ; Vaithianathan, Rhema .
    In: Journal of Public Economic Theory.
    RePEc:bla:jpbect:v:17:y:2015:i:6:p:986-1021.

    Full description at Econpapers || Download paper

  13. The commercial contribution of clinical studies for pharmaceutical drugs. (2014). Sood, Ashish ; Stremersch, Stefan ; Kappe, Eelco.
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:31:y:2014:i:1:p:65-77.

    Full description at Econpapers || Download paper

  14. Information technology and agency in physicians prescribing decisions. (2014). Epstein, Andrew J. ; Ketcham, Jonathan D..
    In: RAND Journal of Economics.
    RePEc:bla:randje:v:45:y:2014:i:2:p:422-448.

    Full description at Econpapers || Download paper

  15. Pharmaceutical Followers. (2013). Ridley, David ; Ellickson, Paul ; Landry, Peter ; Arcidiacono, Peter .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19522.

    Full description at Econpapers || Download paper

  16. What is the value of ‘me-too’ drugs?. (2013). Regnier, Stephane .
    In: Health Care Management Science.
    RePEc:kap:hcarem:v:16:y:2013:i:4:p:300-313.

    Full description at Econpapers || Download paper

  17. Pharmaceutical advertising and Medicare Part D. (2013). Sood, Neeraj ; Lakdawalla, Darius ; Gu, Qian .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:6:p:1356-1367.

    Full description at Econpapers || Download paper

  18. Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?. (2013). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:1:p:268-285.

    Full description at Econpapers || Download paper

  19. Drug withdrawals and the utilization of therapeutic substitutes: The case of Vioxx. (2013). Simon, Kosali I. ; Tennyson, Sharon ; Collins, Michael J..
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:86:y:2013:i:c:p:148-168.

    Full description at Econpapers || Download paper

  20. Pharmaceutical followers. (2013). Ridley, David ; Landry, Peter ; Arcidiacono, Peter ; Ellickson, Paul B..
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:5:p:538-553.

    Full description at Econpapers || Download paper

  21. Informing the uninformed: How drug advertising affects check-up visits. (2013). Wendling, Brett ; Hosken, Daniel .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:181-194.

    Full description at Econpapers || Download paper

  22. The impact of scientific research on health care: Evidence from the OECD countries. (2013). Moscone, Francesco ; Tosetti, Elisa ; Costantini, Marco ; Ali, Maged .
    In: Economic Modelling.
    RePEc:eee:ecmode:v:32:y:2013:i:c:p:325-332.

    Full description at Econpapers || Download paper

  23. Pricing dynamics and product quality: the case of antidepressant drugs. (2012). Rizzo, John ; Chen, Jie.
    In: Empirical Economics.
    RePEc:spr:empeco:v:42:y:2012:i:1:p:279-300.

    Full description at Econpapers || Download paper

  24. Physician response to financial incentives when choosing drugs to treat breast cancer. (2012). Johnson, Scott ; Epstein, Andrew .
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:12:y:2012:i:4:p:285-302.

    Full description at Econpapers || Download paper

  25. Getting Competition Down to a Science: The Effects of Technological Competition on Firms Scientific Publications. (2012). Polidoro, Francisco ; Theeke, Matt .
    In: Organization Science.
    RePEc:inm:ororsc:v:23:y:2012:i:4:p:1135-1153.

    Full description at Econpapers || Download paper

  26. The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: Empirical findings and public policy implications. (2011). Liu, Qiang ; Gupta, Sachin.
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:28:y:2011:i:3:p:205-217.

    Full description at Econpapers || Download paper

  27. Does Patient Use of Medical Information Affect Physician Practice Incentives to Provide Care?. (2011). Rizzo, John ; Fang, Hai .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:14:y:2011:i:2:n:2.

    Full description at Econpapers || Download paper

  28. The effects of detailing on prescribing decisions under quality uncertainty. (2010). Ching, Andrew ; Ishihara, Masakazu.
    In: Quantitative Marketing and Economics (QME).
    RePEc:kap:qmktec:v:8:y:2010:i:2:p:123-165.

    Full description at Econpapers || Download paper

  29. Deviation Among Technology Reviews: An Informative Enrichment of Technology Evolution Theory for Marketing. (2010). Stremersch, Stefan ; Sood, A..
    In: ERIM Report Series Research in Management.
    RePEc:ems:eureri:17766.

    Full description at Econpapers || Download paper

  30. Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?. (2010). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8076.

    Full description at Econpapers || Download paper

  31. Incentives for clinical trials. (2009). Grönqvist, Erik ; Lundin, Douglas ; Gronqvist, Erik.
    In: Economics of Innovation and New Technology.
    RePEc:taf:ecinnt:v:18:y:2009:i:5:p:513-531.

    Full description at Econpapers || Download paper

  32. Information, learning, and drug diffusion: The case of Cox-2 inhibitors. (2009). Chintagunta, Pradeep ; Jiang, Renna ; Jin, Ginger.
    In: Quantitative Marketing and Economics (QME).
    RePEc:kap:qmktec:v:7:y:2009:i:4:p:399-443.

    Full description at Econpapers || Download paper

  33. Knowledge and information flows in supply chains: A study on pharmaceutical companies. (2009). Nakano, Davi ; Pedroso, Marcelo Caldeira .
    In: International Journal of Production Economics.
    RePEc:eee:proeco:v:122:y:2009:i:1:p:376-384.

    Full description at Econpapers || Download paper

  34. Patient education and the impact of new medical research. (2009). Simon, Kosali ; Price, Joseph.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1166-1174.

    Full description at Econpapers || Download paper

  35. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. (2009). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1141-1153.

    Full description at Econpapers || Download paper

  36. Trials, tricks and transparency: how disclosure rules affect clinical knowledge. (2008). González, Paula ; Dahm, Matthias ; Gonzalez, Paula ; Fresco, Nicolas Porteiro .
    In: Working Papers.
    RePEc:urv:wpaper:2072/5360.

    Full description at Econpapers || Download paper

  37. Trials, Tricks and Transparency: How Disclosure Rules Affect Clinical Knowledge. (2008). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Working Papers.
    RePEc:pab:wpaper:08.02.

    Full description at Econpapers || Download paper

  38. Generalizations on the effectiveness of pharmaceutical promotional expenditures. (2008). , Sara ; Wieringa, Jaap E ; PEter, .
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:25:y:2008:i:4:p:234-246.

    Full description at Econpapers || Download paper

  39. The Effects of Detailing on Prescribing Decisions under Two-Sided Learning. (2007). Ching, Andrew ; Ishihara, Masakazu.
    In: MPRA Paper.
    RePEc:pra:mprapa:4935.

    Full description at Econpapers || Download paper

  40. The Debate on Influencing Doctors Decisions: Are Drug Characteristics the Missing Link?. (2007). Venkataraman, Sriram ; Stremersch, Stefan .
    In: Management Science.
    RePEc:inm:ormnsc:v:53:y:2007:i:11:p:1688-1701.

    Full description at Econpapers || Download paper

  41. The Debate on Influencing Doctors’ Decisions: Are Drug Characteristics the Missing Link?. (2007). Stremersch, Stefan ; Venkataraman, S..
    In: ERIM Report Series Research in Management.
    RePEc:ems:eureri:10520.

    Full description at Econpapers || Download paper

  42. Incentives for Clinical Trials. (2006). Grönqvist, Erik ; Lundin, Douglas ; Gronqvist, Erik.
    In: SSE/EFI Working Paper Series in Economics and Finance.
    RePEc:hhs:hastef:0636.

    Full description at Econpapers || Download paper

  43. Direct to consumer advertising in pharmaceutical markets. (2006). Kuhn, Michael ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:25:y:2006:i:1:p:102-130.

    Full description at Econpapers || Download paper

  44. The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply. (2005). DiMasi, Joseph ; Paquette, Cherie .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:23:y:2005:i:12:p:1193-1202.

    Full description at Econpapers || Download paper

  45. The Competitive Effects of Drug Withdrawals. (2005). Rizzo, John ; Cawley, John.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11223.

    Full description at Econpapers || Download paper

  46. Direct to Consumer Advertising in Pharmaceutical Markets. (2005). Kuhn, Michael ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_1493.

    Full description at Econpapers || Download paper

  47. Are Physicians ÜEasy MarksÝ? Quantifying the Effects of Detailing and Sampling on New Prescriptions. (2004). Mizik, Natalie ; Jacobson, Robert .
    In: Management Science.
    RePEc:inm:ormnsc:v:50:y:2004:i:12:p:1704-1715.

    Full description at Econpapers || Download paper

  48. An empirical model of learning and patient spillovers in new drug entry. (2004). Shum, Matthew ; Coscelli, Andrea .
    In: Journal of Econometrics.
    RePEc:eee:econom:v:122:y:2004:i:2:p:213-246.

    Full description at Econpapers || Download paper

  49. Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs. (2002). Winston, Clifford ; Stempski, Randolph ; Calfee, John E..
    In: Journal of Law and Economics.
    RePEc:ucp:jlawec:doi:10.1086/374704.

    Full description at Econpapers || Download paper

  50. Dynamic R&D and the Effectiveness of Policy Intervention in the Pharmaceutical Industry. (). Kryukov, Yaroslav .
    In: GSIA Working Papers.
    RePEc:cmu:gsiawp:-1122776787.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-02-01 13:00:20 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.